Nu-Med Plus, Inc. financial data

Symbol
NUMD on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
455 East 500 South, Suite #203, Salt Lake City, UT
State of incorporation
Utah
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 11.5 %
Debt-to-equity -113 %
Return On Equity 539 %
Return On Assets -655 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 83.5M shares +2.7%
Common Stock, Shares, Outstanding 83.5M shares +2.7%
Entity Public Float 872K USD +12.4%
Common Stock, Value, Issued 83.5K USD +2.7%
Weighted Average Number of Shares Outstanding, Basic 83.5M shares +2.7%
Weighted Average Number of Shares Outstanding, Diluted 83.5M shares +2.7%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 27.1K USD -9.66%
Operating Income (Loss) -114K USD +23.6%
Nonoperating Income (Expense) -1.25K USD -1.14%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -16.4K USD +71.7%
Net Income (Loss) Attributable to Parent -119K USD -17.1%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 3.5K USD
Other Assets, Current 5.14K USD
Assets, Current 9.02K USD -84.7%
Property, Plant and Equipment, Net 251 USD -97.2%
Operating Lease, Right-of-Use Asset 5.14K USD +3.01%
Assets 9.02K USD -84.7%
Accounts Payable, Current 16.5K USD +20.2%
Accrued Liabilities, Current 14.5K USD +551%
Liabilities, Current 178K USD +18.2%
Liabilities 178K USD +18.2%
Retained Earnings (Accumulated Deficit) -9.85M USD -1.23%
Stockholders' Equity Attributable to Parent -169K USD -84.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -189K USD -199%
Liabilities and Equity 9.02K USD -84.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -450 USD +97.8%
Net Cash Provided by (Used in) Investing Activities 3K USD
Common Stock, Shares Authorized 90M shares 0%
Common Stock, Shares, Issued 83.5M shares +2.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -450 USD +97.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.36K USD -88%
Deferred Tax Assets, Valuation Allowance 2.2M USD +6.17%
Operating Lease, Liability 5.14K USD +3.01%
Depreciation 8.73K USD -23.4%
Property, Plant and Equipment, Gross 83.9K USD 0%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Deferred Tax Assets, Operating Loss Carryforwards 2.2M USD +6.06%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 9.59M USD +0.41%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 90M USD
Interest Expense 1.25K USD +1.14%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%